PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.\', \'Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.\', \'Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.\', \'Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria.\', \'Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria. Electronic address: selma.tobudic@meduniwien.ac.at.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2059-7029(20)32713-710.1136/esmoopen-2020-000889
?:hasPublicationType
?:journal
  • ESMO open
is ?:pmid of
?:pmid
?:pmid
  • 32878898
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all